307 related articles for article (PubMed ID: 19735089)
1. Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease.
Sauleau P; Leray E; Rouaud T; Drapier S; Drapier D; Blanchard S; Drillet G; Péron J; Vérin M
Mov Disord; 2009 Oct; 24(14):2149-55. PubMed ID: 19735089
[TBL] [Abstract][Full Text] [Related]
2. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
[TBL] [Abstract][Full Text] [Related]
3. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight.
Macia F; Perlemoine C; Coman I; Guehl D; Burbaud P; Cuny E; Gin H; Rigalleau V; Tison F
Mov Disord; 2004 Feb; 19(2):206-12. PubMed ID: 14978678
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.
Volkmann J; Albanese A; Kulisevsky J; Tornqvist AL; Houeto JL; Pidoux B; Bonnet AM; Mendes A; Benabid AL; Fraix V; Van Blercom N; Xie J; Obeso J; Rodriguez-Oroz MC; Guridi J; Schnitzler A; Timmermann L; Gironell AA; Molet J; Pascual-Sedano B; Rehncrona S; Moro E; Lang AC; Lozano AM; Bentivoglio AR; Scerrati M; Contarino MF; Romito L; Janssens M; Agid Y
Mov Disord; 2009 Jun; 24(8):1154-61. PubMed ID: 19412954
[TBL] [Abstract][Full Text] [Related]
7. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease.
Evidente VG; Premkumar AP; Adler CH; Caviness JN; Driver-Dunckley E; Lyons MK
Acta Neurol Scand; 2011 Sep; 124(3):211-4. PubMed ID: 20969559
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.
Montaurier C; Morio B; Bannier S; Derost P; Arnaud P; Brandolini-Bunlon M; Giraudet C; Boirie Y; Durif F
Brain; 2007 Jul; 130(Pt 7):1808-18. PubMed ID: 17535833
[TBL] [Abstract][Full Text] [Related]
9. Increase in body weight is a non-motor side effect of deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
Novakova L; Ruzicka E; Jech R; Serranova T; Dusek P; Urgosik D
Neuro Endocrinol Lett; 2007 Feb; 28(1):21-5. PubMed ID: 17277730
[TBL] [Abstract][Full Text] [Related]
10. Body weight gain rate in patients with Parkinson's disease and deep brain stimulation.
Barichella M; Marczewska AM; Mariani C; Landi A; Vairo A; Pezzoli G
Mov Disord; 2003 Nov; 18(11):1337-40. PubMed ID: 14639677
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease.
Rothlind JC; Cockshott RW; Starr PA; Marks WJ
J Int Neuropsychol Soc; 2007 Jan; 13(1):68-79. PubMed ID: 17166305
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
[TBL] [Abstract][Full Text] [Related]
13. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
14. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
[TBL] [Abstract][Full Text] [Related]
15. Globus pallidus stimulation in advanced Parkinson's disease.
Rodrigues JP; Walters SE; Watson P; Stell R; Mastaglia FL
J Clin Neurosci; 2007 Mar; 14(3):208-15. PubMed ID: 17150360
[TBL] [Abstract][Full Text] [Related]
16. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
[TBL] [Abstract][Full Text] [Related]
17. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
[TBL] [Abstract][Full Text] [Related]
19. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
